Search Results

Keywords: tilray

Tilray inks first deal to buy adult-use cannabis retailer in Canada for CA$110 million

Canadian cannabis producer Tilray is expanding into Alberta’s competitive recreational marijuana market with the planned acquisition of retailer Four20 for 110 million Canadian dollars ($82 million). It is Tilray’s first agreement to acquire a cannabis retailer in Canada outright after taking small positions in Spiritleaf and Westleaf. Four20 has six of Alberta’s 277 adult-use cannabis locations. The definitive […]

Read More

Cannabis firm Tilray’s revenue up, but wider loss reported

Canadian marijuana company Tilray on Tuesday reported revenue of 60.9 million Canadian dollars ($45.9 million) for the second quarter, up almost four times from the same period in 2018. Net loss for the period, which ended June 30, was $35.05 million compared with a $12.83 million loss in the second quarter 2018. Tilray, based in […]

Read More

Marijuana firm Tilray revenue up nearly 200% in Q1; net loss grows on spending

Tilray, a British Columbia, Canada-based cannabis cultivator and distributor, reported revenue of $23 million for the first quarter of 2019, up 195% from the same period last year. The company’s net loss, however, widened nearly sixfold on higher spending. Tilray, which reports its earnings in U.S. dollars, said in a news release the sales gain […]

Read More

Tilray expects GMP approval, first cannabis sales from Portugal this summer

Tilray’s facility in Portugal is expected to receive Good Manufacturing Practice (GMP) certification in the coming months, which the Canada-based cannabis company says will open the door for the first shipments from its European facility as early as this summer. Monetizing European demand for medical cannabis is core to the strategies of many publicly traded cannabis […]

Read More

Marijuana firm Tilray taps ex-Goldman Sachs managing director

Canadian marijuana cultivator Tilray said it is hiring former Goldman Sachs Managing Director Andrew Pucher as chief corporate development officer. Pucher – the latest Wall Street executive to enter the marijuana industry – most recently covered cannabis stocks for Goldman as part of his role as managing director and head of Canadian Diversified Investment Banking. At […]

Read More

Tilray to accelerate expansion into CBD with Manitoba Harvest acquisition

Cannabis giant Tilray is expanding into the natural foods category with the acquisition of hemp foods company Manitoba Harvest for 419 million Canadian dollars ($319 million) in cash and stock in an effort to capitalize on cannabidiol-infused products in North America. The acquisition will accelerate British Columbia-based Tilray’s expansion into the U.S. and Canadian markets […]

Read More

Tilray to double domestic footprint with acquisition of Canadian marijuana cultivator

British Columbia-based Tilray plans to buy Natura Naturals Holdings for up to 70 million Canadian dollars ($52 million) to significantly increase its Canadian cannabis footprint. Natura Naturals – a subsidiary of Natura Naturals Holdings – owns one of Canada’s 126 cannabis cultivation licenses. Under the terms of the definitive agreement, Tilray said it will deliver […]

Read More

Tilray, Authentic Brands Group enter revenue-sharing deal for cannabis products

Tilray, the British Columbia-based cannabis heavyweight, signed a revenue-sharing agreement with Authentic Brands Group (ABG) to market and distribute consumer cannabis products within the New York-based firm’s brand portfolio. Under the terms of the agreement, Tilray will pay $100 million to ABG and up to $250 million in cash and stock upon achieving unspecified milestones. […]

Read More

Budweiser maker AB InBev teams with Tilray in $100 million deal to research marijuana-infused drinks

Two commercial giants from the worlds of beer and marijuana are teaming up to spend $100 million to research cannabis-infused beverages, the latest deal to pair a Canadian cannabis company with a major maker of alcoholic beverages. Belgium-based AB InBev (NYSE: BUD), which includes Budweiser in its huge portfolio of beer brands, is partnering with […]

Read More

Canadian medical cannabis firm Tilray eyes global reach in deal with Novartis subsidiary

British Columbia-based Tilray reached an agreement with a subsidiary of Swiss pharmaceutical giant Novartis AG in which the Canadian firm’s medical marijuana will eventually be produced and distributed in countries where MMJ is legal. Tilray’s deal with Quebec-based Sandoz AG is an extension of a letter of intent the companies signed in March to produce co-branded, nonsmokable and noncombustible […]

Read More

IGC Resources, Westleaf Cannabis close CA$20M raise, including Tilray investment

Alberta marijuana companies IGC Resources (TSXV: IGC.H) and Westleaf Cannabis closed a brokered private placement of 20 million Canadian dollars ($15 million), including CA$2.9 million from British Columbia-based Tilray. The capital raise was completed in connection with Westleaf’s proposed reverse takeover of IGC, which received conditional approval from the TSX Venture Exchange. The company plans to […]

Read More